|
|
Industry Trends
Clinical Research
Off-shoring
By Mark P. Mathieu
For
many years, pharmaceutical
companies have been off-shoring
manufacturing operations to
lower-cost countries. Healthy
margins and strong risk aversion
have afforded pharmaceutical
companies the luxury of staying
close to home, for all but
manufacturing activities. As
financial pressures increase,
pharmaceutical executives are
finding that going offshore is not
only less risky than it once was,
but also too attractive to
ignore.
Read more.
|
|
|
Sales Contacts
For advertising
information contact:
Alan El
Faye
VP, Advertising Sales - Western
US, Canada, Europe, Pacific Rim
213-300-3886
John J.
Kistner
Account Manager, Multi-Media
Advertising
781-972-1354
|
|
|
|
Contact the
editors
Contributing
Editor
Deborah
Borfitz
covers development
planning and protocol design;
investigative site selection and
management; and patient recruitment
and retention.
Contributing
Editor
Ann Neuer
covers project
management, operations, and
outsourcing, as well as data
collection, data management, and
electronic data capture. Ann has
been writing in the clinical trials
sector since 1995.
|
|
|
|
Link to Us!
You are welcome to link to
articles on our website. Contact
Allison Proffitt
for details.
e-Prints &
Reprints
To post a full article
from
eCliniqua
or
Bio-IT World
on your website (not just a link),
or for paper reprints, please
contact:
Ashley
Zander
The YGS Group
717-505-9701 ext.125
|
|
|
|
Follow
eCliniqua
on Twitter
|
|
|
|
|
|
|
IN THIS ISSUE
|
|
DIA 2010 -
Innovation, Issues-Driven,
Upbeat
|
|
|
Most Approved Drugs
Tested Overseas
|
|
|
News Briefs
|
|
| |
|
|
Electronic
Lab
Notebook:
How
a
CRO
Improved
Productivity
25%
Kalexsyn
chose
to
implement
an
ELN--instead
of
paper--from
Day
One.
Resulting
benefits:
-
25%
more
productive
-
Faster,
easier
reporting
-
Cost
savings
|
|
|
| |
|
DIA
TRENDS
DIA 2010 -
Innovation, Issues-Driven,
Upbeat
By Ann Neuer
The 46th Annual
Meeting of the Drug
Information Association (DIA)
held last month in
Washington, D.C. sported a
decidedly optimistic tone. A
whole host of sessions and
exhibits highlighted
strategic partnerships among
multiple stakeholders, the
growing role of payers and
comparative effectiveness
research, electronic health
records, continued
globalization, and of course,
the latest technological
solutions.
Read more
.
|
|
| |
|
| |
| |
|
REGULATORY
Most Approved Drugs
Tested Overseas
New York Times |
The inspector general of the
HHS released a report stating
that 80% of the drugs
approved for sale in 2008 had
trials in foreign countries
and 78% of all subjects that
participated in clinical
trials were enrolled at
foreign sites.
Read more
.
|
|
| |
|
Most-Read Story from
Previous Issue
DIA Bits & Pieces
|
| |
| |
|
| |
| |
|
LIFE
SCIENCE JOBS
Software
Engineer -
Computational Biology
Center
Memorial
Sloan-Kettering
Cancer Center seeks
an Engineer to design
and develop complex
data analysis systems
in support of cancer
genomics research
projects at the
Computational Biology
Center. Qualified
candidate will have a
BA, 5+ years of
software development
experience and expert
knowledge of Java,
SQL, and HTML.
Apply:
www.mskcciscareers.org
. Equal
opportunity and
affirmative action
employer.
Cambridge Bio
Collaborative
Conference
Producer,
Needham,
Massachusetts
Responsibilities:
Develop live/virtual
events re: IT, data
management and
informatics in the
life sciences;
conduct phone
interviews and
literary review
regarding source
material, topic
validation, content
development and
thought leader
recruitment.
Qualifications: Life
science
informatics/IT degree
or equivalent;
expertise in
supercomputing,
bio/cheminformatics,
knowledge management,
software development,
workflow tools, cloud
computing, and/or
biostatistics;
communication and
relationship
management skills;
strong project
management skills,
exceptional
creativity;
willingness and
ability to travel.
Click here
for the full job
posting.
Apply:
ssamson@healthtech.com
To have your job
openings featured here,
contact
Lynn Cloonan
for more
information.
|
|
| |
|
SPONSORED LINKS
To have your product or
service featured here,
contact
Lynn Cloonan
for more
information.
|
|
| |
|
Insight
Pharma Reports
Inflammatory
Disorders:
Therapies That
Suppress or Balance
the Immune Response
Author: Lucy J.
Sannes, Ph.D.,
MBA
The
human immune system can
go awry, either attacking
an individual's body or
producing an exaggerated
response to a foreign
substance that is
normally benign. In these
situations,
immunotherapies are
needed to balance or
suppress the unwarranted
immune response.
This report reviews
the problems of
insufficient efficacy,
side effects, and adverse
events associated with
the small-molecule and
biological drugs
available today to treat
these
disorders.
Read more
.
|
|
| |
|
FEATURED
EVENTS
-
The Immunotherapeutics
& Vaccine
Summit
- August 17-19,
2010. Cambridge,
MA
-
The Bioprocessing
Summit
- August 23-26,
2010, Boston, MA
-
Next Generation Dx
Summit
- August 24-26,
2010, Washington,
DC
-
ADAPT 2010:
Accelerating
Development &
Advancing Personalized
Therapy
- September 13-15,
2010, Arlington,
VA
-
Next-Generation
Sequencing Data
Management
- September 27-29,
2010, Providence,
RI
-
Bio-IT World Europe
- October 5-7,
2010, Hannover
Germany
-
Immunogenicity
Summit
- October 19-21,
2010, Philadelphia,
PA
-
Discovery on Target
- November 2-4,
2010, Boston, MA
To have your event featured
here, contact
Lynn
Cloonan
for more information.
|
|
|
|
|
|
|
Upcoming
Clinical
Web Symposiums
|
|
|
Leveraging BPM
to Increase
Efficiencies in
Clinical Trial Case
Management sponsored by
Pegasystems
August 3, 2010,
1:00pm eastern
Clinical Trial Case
Management encompasses
many complex processes.
Business Process
Management (BPM) suites
have the ability to
provide all the necessary
components for automating
those processes ranging
from protocol
development, investigator
and patient enrollment to
adverse event processing
and reporting. These
examples all involve
multiple applications,
people, rules and
information whereby
people collaborate and
dynamically take action
according to specific
regulatory guidelines,
studies and locales.
Today, life sciences
organizations are looking
toward BPM to solve
issues around control,
visibility and
compliance. Additionally,
they are looking for the
Holy Grail to "bridge the
gap" between the myriad
of systems in use today
including CTMS, CDMS,
safety systems, ERP
systems and ECM systems.
Register Today!
|
|
|
|
|
Cloud
Computing in Life
Sciences
R&D
|
|
Cloud
computing is rapidly
growing in importance as
life science R&D
organizations are deluged
with data from multiple
sources.
Simultaneously, demand for
computationally complex
modeling and simulation
studies continues to rise
dramatically.
Limited
funding and budgets make it
difficult for many
organizations to build the
infrastructure necessary to
keep pace with these
challenges, and as a result,
cloud computing appears for
many to be a promising
alternative to in-house
expansion.
To learn
more about Cloud Computing and
this new report scheduled to
release in early April,
click here
.
|
|
|
|
FEATURED CONTENT
|
|
Next-gen Cloud-based
eClinical
New technologies are
available to leverage Cloud
Computing in managing
clinical trial data. This
paper discusses a next
generation eClinical
platform.
Download Now
(Sponsored by: Cmed
Technology)
Optimizing Value in
Clinical Data as
Standards
Evolve
Facing pipeline
difficulties,
increasing costs
and timeline
pressures, more
biopharmaceutical
companies are
looking into
standards as a tool
for data
integration and
analysis leading to
better decisions.
Standards operate
in a highly complex
environment, are
somewhat immature,
and are continuing
to evolve.
Presently, even the
most progressive
adopters face
hurdles in
implementing
standards
value
Download Now
(Sponsored by:
Oracle)
Scalable Storage for Life
Sciences
Download this whitepaper to
learn how Partners HealthCare
Center for Personalized
Genetic Medicine is
addressing their ongoing data
storage demands that had
started to hinder the
progress of biomedical
research. They now offer
pay-as-you-grow storage,
capable of handling rapidly
increasing volumes of data
without compromising
performance. Registration
page url:
Download Now
(Sponsored by: HP)
To have
your white paper featured
here, contact
Lynn
Cloonan
for more
information.
|
|
|
|
EXCLUSIVE WEBCAST
|
|
Breaking Through the
REAL World Data Storage
Barriers for Next Gen
Sequencing
The current crop of
next-generation sequencers
(NGS) produce a much richer set
of data per sequencing run,
offer researchers more insight
into the biological systems
they are studying, perform
their work faster than before,
and frequently cost less to
run. However, such lab
equipment places new demands on
life sciences storage
solutions. The reason: Each
faster and more frequent run
produces an order of magnitude
more data than was the case
with previous generation
systems.
Download the
webcast
(Sponsored by: BlueArc)
Trends in High
Throughput Virtual Screening
For accelerating
structure-based drug design
Schrödinger's GLIDE docking
software and HP Cluster
Platforms together help address
the needs of individual
scientists, research groups or
datacenters while offering new
possibilities for greatly
enhanced productivity with a
reduction in development
costs.
Download the
webcast
(Sponsored by: HP)
|
|
|
|
